BridgeBio’s drug for ATTR-CM gains US FDA approval
BridgeBio plans to price the therapy at $18,759.12 for a 28-day supply
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
pharma
Biologic therapies show progress in severe asthma treatment and remission potential
Barriers such as cost and accessibility highlight the urgent need for equitable healthcare solutions to ensure widespread adoption…
Alembic Pharma gets form 483 with five procedural observations by USFDA
The GMP inspection was conducted at the company’s Jarod facility
Pharmaceuticals & Medical Devices Bureau of India participates in 43rd Edition of IITF 2024
The Government aims to expand the reach of PMBJP by increasing the number of Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs)…
Lupin’s ESG score rises to 76 in S&P Global ESG Ratings
The company has increased its share of use of renewable energy to 33.8 per cent and reduced carbon emissions by 21 per cent over…
Optimising cloud provisioning for pharmaceutical compliance and operational excellence
Suresh Perikala, Senior Engineering Lead – DevOps and Cloud Engineering Practice, Altimetrik explains how the industry can obtain…
Accelerating pharma’s sustainability efforts
Avinaw Prasad, Director, Climate Change & Sustainability, Deloitte India explains why integrating sustainability into the core…
CAR T cell therapies to promote drug-free remission in lupus care
BMS’s CC-97540 and Cabaletta Bio’s CABA-201 highlight CAR T’s potential to achieve lasting drug-free remission, marking a…
17th edition of CPHI & PMEC India expo to be held from Nov 26-28, 2024
As a comprehensive, one-stop destination for innovative, cost-effective solutions, the expo will showcase the pharmaceutical…
Alembic Pharma gains USFDA final approval for Ivabradine Tablets, 5 mg and 7.5 mg
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Corlanor Tablets, 5 mg and 7.5 mg, of…